Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.01 | 47.43 |
| PEG Ratio (TTM) | 0.00 | -0.37 |
| P/S Ratio (TTM) | 1.21 | 6.17 |
| P/B Ratio (TTM) | 0.01 | 6.03 |
| P/FCF Ratio (TTM) | -0.21 | 41.68 |
| Price to 5YR AVG Earnings Ratio | N/A | 58.57 |
| Price to 5YR AVG FCF Ratio | N/A | 34.18 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -86.61% | 5.30% |
| ROE (TTM) | -187.00% | 28.25% |
| Net Profit Margin (TTM) | -648.92% | 8.25% |
| ROIC 5YR AVG | N/A | 6.60% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 29.28% | -25.16% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | 2.67% | -142.43% | N/A |
| Cash Flow | -19.31% | -255.26% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.38 | 2.90 |
| Quick Ratio (TTM) | 4.38 | 2.17 |
| D/E Ratio (TTM) | 0.05 | 0.61 |
| Interest Coverage (TTM) | -9.77 | 22.17 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 7.62 |
| LTL to 5YR AVG FCF | N/A | 3.53 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.60% |